U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market

 

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, organ transplantation, cardiovascular disorders, infectious diseases, and other indications. Major market challenges, drivers, and restraints and identified and discussed.

Table of Contents

U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market, Executive SummaryExecutive SummaryIntroductionU.S. Biotechnology - Therapeutic Monoclonal Antibodies Market, Market IntroductionResearch Scope and MethodologyScope & SegmentationResearch MethodologyMarket OverviewMarket Engineering MeasurementsTechnology OverviewDisease Overviews - OncologyDisease Overviews - Autoimmune and Inflammatory DisordersDisease Overviews - Organ TransplantationDisease Overviews - Cardiovascular DisordersDisease Overview - Infectious DiseasesDisease Overviews - Other DiseasesIndustry TrendsIndustry ChallengesMarket DriversMarket RestraintsProduct AnalysisOncologyAutoimmune and Inflammatory DisordersOrgan TransplantationCardiovascular DisordersInfectious DiseasesOther IndicationsPipeline AnalysisOncologyAutoimmune and Inflammatory DisordersOrgan TransplantationCardiovascular DisordersInfectious DiseasesOther IndicationsAdditional Indications for Marketed ProductsU.S. Biotechnology - Therapeutic Monoclonal Antibodies Market, Competitive AnalysisCompetitive AnalysisCompetitive StructureForecasts and TrendsTotal MarketOncologyAutoimmune and Inflammatory DisordersOrgan TransplantationCardiovascular DisordersInfectious DiseasesOther IndicationsMarket Share AnalysisCompany Market ShareProduct Market ShareU.S. Biotechnology - Therapeutic Monoclonal Antibodies Market, Decision Support DatabasesOncology DatabasesIncidence of Colon Rectum CancerTotal Cancer CasesIncidence of Bladder CancerIncidence of Breast CancerIncidence of Lung CancerIncidence of Stomach CancerAutoimmune and Inflammatory Disorders DatabasesPrevalence of AsthmaPrevalence of ArthritisTotal Cases of Multiple SclerosisPrevalence of PsoriasisOrgan Transplant DatabasesTotal Number of Kidney TransplantsTotal of Heart TransplantsTotal Number of Liver TransplantsCardiovascular DatabasesPrevalence of Cardiovascular DiseasesPrevalence of Coronary Heart DiseaseOther Indications DatabasesPrevalence of Age-Related Macular Degeneration (AMD)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 30-Oct-17

Region : North America

Release Date : 25-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.